Futility Designs

Sharon D. Yeatts () and Yuko Y. Palesch ()
Additional contact information
Sharon D. Yeatts: Medical University of South Carolina, Data Coordination Unit, Department of Public Health Sciences
Yuko Y. Palesch: Medical University of South Carolina, Data Coordination Unit, Department of Public Health Sciences

Chapter 58 in Principles and Practice of Clinical Trials, 2022, pp 1067-1082 from Springer

Abstract: Abstract Limited resources require that interventions be evaluated for an efficacy signal in Phase II prior to initiation of large and costly confirmatory Phase III clinical trials. The standard concurrently controlled superiority design is not well-suited for this evaluation. Because the Phase II superiority design is often underpowered to detect clinically meaningful improvements, investigators are left to make subjective decisions in the face of a nonsignificant test result. The futility design reframes the statistical hypothesis in order to discard interventions which do not demonstrate sufficient promise. The alternative hypothesis is that the effect is less than some minimally worthwhile threshold. In this way, the trial can be appropriately powered to evaluate whether the intervention is worth pursuing in Phase III and thus provides a clear “no go” signal. We briefly describe the superiority design in order to compare and contrast with the futility design. We then describe both the single-arm and concurrently controlled futility designs and present case studies of each. Lastly, we discuss some key considerations related to sample size calculation and interim analysis.

Keywords: Phase II; Futility design; Single-arm futility design; Concurrently controlled futility design; Calibration control (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-52636-2_83

Ordering information: This item can be ordered from
http://www.springer.com/9783319526362

DOI: 10.1007/978-3-319-52636-2_83

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().